Luteal phospholipase A2 activity increases during functional and structural luteolysis in pregnant rats  by Kurusu, S. et al.
FEBS 21857 FEBS Letters 454 (19993 225 228 
Luteal phospholipase A2 activity increases during functional and 
structural luteolysis in pregnant rats 
S. Kurusu*, K. Kaizo, M. Ibashi, M. Kawaminami, I. Hashirnoto 
Laboratory q[' Veterinary Physiology, Kitasato Univet~'ity School of Veterinary Medicine and Animal Sciences, Towada, Aomori 034-8628, Japan 
Received 20 January 1999; received in revised form 12 March 1999 
Abstract We determined eytosolic phospholipase A2 activity of 
the corpus luteum during luteolysis in pregnant and post-partum 
rats. Phospholipase A2 activity and its metabolite prostaglandin 
F2~ in the corpus luteum remarkably increased just before 
parturition and further rose transiently during post-partum 
structural luteolysis. The absence of a pups' suckling stimulus 
delayed corpus luteum involution, being associated with an 
altered fluctuation in phospholipase A2 activity and depressed 
prostaglandin Fz~ levels. Exogenous prolactin had a reversal 
effect. Pharmacological and immunochemical characterization 
suggests multiple isoforms of phospholipase A2 in a pregnant 
corpus luteum. These results show the increased phospholipase 
A2 activity and its possible implication in luteolysis in pregnant 
rats. 
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Key words: Phospholipase A2 ; Luteolysis; Parturition; Rat ; 
Prostaglandin F2~ 
1. Introduction 
Phospholipase A2 (PLA2) is a key enzyme that generates a 
variety of lipid mediators. These biologically active substances 
include free fatty acids, lysophospholipids and eicosanoids 
such as prostaglandin (PG) and leukotriene. PEA2 comprises 
a growing superfamily and those of mammalian origin are 
largely divided into four groups according to a recent classi- 
fication [1]. The first group of enzymes (sPLA2), 14 kDa, is 
secreted and dependent on a mM level Ca 2+, being further 
divided into subtypes IB, IIA, IIC, V, etc. The second group 
of enzymes (cPLA2), 85 kDa, is cytosolic and activated by 
sub-~tM Ca 2+ levels. The third PLA2 group (iPLA2), 80-85 
kDa, is also cytosolic but Ca2+-independent. The last group 
of enzymes is Ca2+-independent and they have an acetylhy- 
drolase activity for platelet activating factor. 
Eicosanoids exert a wide range of physiological and patho- 
logical effects in the body. PGF2c~ acts on the cell surface 
specific receptor (FP) of the corpus luteum (CL) to induce 
luteolysis in mammals [2]. Luteolysis in rats is composed of 
functional luteolysis, characterized by a decline in the circu- 
lating progesterone l vel, and the subsequent s ructural luteol- 
ysis, marked by CL involution [3]. The potent luteolysin 
PGF2c~ can be generated by CL itself [2] and rat CL expresses 
type IB and IIA PLA2 and cPLA: [4 6]. Luteal cytosolic 
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PLA2 activity, mainly exhibited by cPLA2, is shown to in- 
crease during functional luteolysis in pseudopregnant rats 
[5,7]. Mice lacking cPLA2 [8,9] or the FP receptor [10] failed 
to deliver because of obstructed luteolysis at term. This sug- 
gests the indispensable role of cPLA2 in PGF2a generation 
which causes functional luteolysis and induction of delivery. 
However, the dynamics in luteal PLA2 activity during func- 
tional luteolysis in pregnant animals, including rats, is not yet 
fully understood. In addition, it is unclear whether PLA2 and 
one of its metabolites PGF2~ are also responsible for struc- 
tural regression. A previous immunohistochemical study 
showed that the signal for cPLA2 in CL became intensified 
with age in the cycling rat ovary [6]. This finding suggests an 
intimate association between PLA2 and the structural involu- 
tion of CL, however, there have been few reports relating 
them. 
We here investigate the above two problems using pregnant 
and post-partum rats. Unlike the CL of cycling or pseudo- 
pregnant rat ovary, the pregnant CL becomes hypertrophied 
during gestation and is bound to undergo post-partum invo- 
lution, thus being a good model to analyze the mechanism of 
structural luteolysis. 
2. Materials and methods 
2.1. Antibodies and chemicals 
The specific antibodies for human cPLA2 and rat PLA2-IB were 
donated by Genetics Institute (Cambridge, MA, USA) [11] and Dr. K. 
Nomura (Shionogi Research Laboratory, Osaka, Japan) [4], respec- 
tively. Radiolabelled phosphatidylcholine (PC) (1-stearoyl-2- 
[5,6,8,9,11,12,14,15-3H]arachidonyl PC) was obtained from DuPont- 
NEN (Boston, MA, USA). Arachidonyl triftuoromethyl ketone 
(ATK) which inhibits cPLA2 [12], methyl arachidonylfluorophospho- 
hate (MAFP) which inhibits both cPLA2 and iPLA2 [13] and bromo- 
enol lactone (BEL) which inhibits iPLA2 [13] were purchased from 
Cayman (Ann Arbor, MI, USA). An ELISA kit for PGF2~ was 
also purchased from Cayman. Ovine prolactin (PRL) was obtained 
from Sigma (St. Louis, MO, USA). All other reagents, including 
dithiothreitol (DTT) an sPLA2 inactivator [14], were of analytical 
grade. 
2.2. Animals 
Mature female rats of the Wistar-Imamichi strain were used in this 
study. Animals howing a regular 4 day estrous cycle were mated with 
fertile male rats on the pro-estrous evening. The day of fertilization 
(vaginal estrus with sperm positive) was designated as day 1 of preg- 
nancy (PRG1). The duration of pregnancy in our colony was 
23.0 + 0.1 days (mean +_ S.E.M., n = 13). To induce delayed structural 
luteolysis of pregnant CLs, mothers in some groups were removed 
from pups immediately after delivery in order to avoid the occurrence 
of any suckling stimulus. To some of these mothers removed from 
pups, PRL (10 IU, intraperitoneal) was injected twice daily from day 
0 post-partum (PP0, the delivering day) to PP2. Animals were killed at 
indicated times. Blood plasma was stored at -20°C until the proges- 
terone assay. Ovaries were stored at -80°C until analyses of the PLA2 
activity and PGF2a level in CLs were performed. 
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2.3. Ass~o q[ PLA: activity in CL cytosol 
PLA2 activity in CL cytosol was measured by the previous method 
with a slight modification [7,15]. Briefly, pregnant CLs that were 
large, round-shaped and rather whitish were separated from the ova- 
ry. With post-partum ovaries, care was taken not to contaminate a 
new generation of CLs, which were small and reddish, since rats have 
post-partum ovulation. CLs were measured for wet weights and ho- 
mogenized in 0.25 M sucrose, 0.25 mM EDTA and 0.05 M Tris-HC1 
(pH 9.0). The homogenates were centrifuged at 105000×g for 1 h and 
the supernatants (cytosol) were determined for their protein concen- 
tration using a Bio-Rad assay kit. Liposomes for substrate were pre- 
pared with radiolabelled and non-radiolabelled PC at a molar ratio of 
1:4. The assay mixtures (200 ~tl in total volume) contained 0.1 M Tris- 
HC1 (pH 9.0), 4 mM CaCl2, 1 mg/ml fatty acid-free bovine serum 
albumin, 2 pM PC and cytosol. In experiments o pharmacologically 
characterize the PLA~ activity, the mixtures further contained 5 #M 
ATK, 2 ~tM MAFP, 50 }aM BEL or 5 mM DTT. The reaction was 
performed at 37°C for 1 h and stopped by adding 1.0 ml Dole's 
reagent. The released fatty acid was extracted and measured for its 
radioactivity by liquid scintillation counting. 
2.4. Assay of plasma progesterone and luteal PGF~ 
Plasma progesterone was assayed using a radioimmunoassay s 
described before [5]. Luteal PGF:~ was determined according to Hi- 
guchi et al. [16] using a commercial ELISA kit. Briefly, pregnant CLs 
were homogenized in 0.05 M phosphate buffer (pH 7.3) containing 
0.1% gelatin and 0.01% merthiolate and then centrifuged at 10 000 × g 
for 20 rain at 4°C. The supernatant was directly assayed for the 
PGF2a content without any extraction or separation from other eico- 
sanoids or lipids. 
2.5. hnmunohistochemistry of cPLA: and PLA2-1B 
The mother with suckling stimulus was killed on PP8 and ovaries 
were fixed in Bouin's fixative containing HgCI~, dehydrated and em- 
bedded in paraffin. Tissues were serially sectioned (6 pm in thickness), 
deparaffinized and examined histologically and immunochemically. 
Some sections were stained by hematoxylin and eosin (HE). Immu- 
nohistochemistry of PEA2 was performed by the previous methods 
with a slight modification [4.6,15]. Endogenous peroxidase was 
blocked by pretreatment with 0.3% H202 in methanol. Sections 
were incubated with anti-cPLA2 (1:1000) or anti-PLA:-IB (1:3000) 
for 1.5 h at room temperature. Visualization of the complex of the 
objective enzyme and the antibody was performed using the Vectas- 
tain Elite ABC staining method and 3,3'-diaminobenzidine tetrahy- 
drochloride as peroxidase substrate. The control method using the 
non-specific rabbit serum gave no positive reaction (data not shown). 
2.6. Statistical anal)'sis 
All data were presented as mean ± S.E.M. of indicated numbers of 
samples. The means among different groups were analyzed by one- 
way ANOVA and Student's t-test. A P value less than 0.05 was 
considered to be significant. 
3. Results and discussion 
Hav ing  determined the luteal PLA2 activity and PGF2a  
level dur ing  late pregnancy  and  post -par tum,  we here show 
their increase just  before partur i t ion and  their fur ther  and  
t rans ient  increase dur ing  post -par tum structura l  uteolysis. 
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Fig. l. Post-partum changes in wet weight (A), PLA2 activity (B) 
and PGF2~ content (C) of CLs. Post-partum rats (with or without 
suckling stimuli or without suckling stimuli but PRL-administered) 
were killed at indicated times. CLs were separated, weighed and 
measured for cytosolic PLA2 activity and PGF2~ levels as described 
in Section 2. Data are mean ± S.E.M. (n > 15 in A, n = 3-4 in B and 
C). *, P<0.05  versus PP0; #, P<0.01 versus PP0; a, P<0.05 ;  
b, P<0.01.  
Table 1 
Changes in plasma progesterone, luteal PLA2 activity and PGF2~ content during late pregnancy 
Period Progesterone (ng/ml) PEA2 activity (pmol/min/mg) PGF2a (pmol/mg) 
PRG19 138.2 +_ 37.6 3.1 ± 0.6 Not tested 
21 84.8±20 3.5_+0.8 0.21 +0.04 
22 33.5 ± 3.0 8.9 ± 3.7 1.00 _+ 0.19" 
23 26.3+ 10.8 15.3± 1.5" 0.58 ± 0.04" 
Pregnant rats were killed at indicated times. Plasma progesterone was measured by a radioimmunoassay. Luteal cytosolic PLA2 activity and 
PGFza levels were determined as described in Section 2. Data are mean + S.E.M. (n = 3, 4). 
*P< 0.05 versus PRG21 within each column. 
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Fig. 2. Effects of several inhibitors on luteal PLA2 activity. CL cy- 
tosol of mothers with suckling stimuli on PP0 or PP5 were incu- 
bated in 0.1 M Tris-HC1 (pH 9.0), 4 mM CaC12, 1 mg/ml BSA, 
2 ~tM PC substrate with or without each inhibitor for 1 h at 37°C. 
The free [3H]AA released by the reaction was extracted and counted 
for its radioactivity. Data are mean + S.E.M. (n = 4). *, P < 0.05 ver- 
sus each control (no inhibitor); #, P< 0.01 versus control. 
First, we present evidence that the luteal PLA2 activity and 
PGF2~ content increase just before parturition. Plasma pro- 
gesterone was maintained at a high level until PRG21 and 
declined to the basal level on PRG22 (Table 1), indicating 
the accomplishment of functional luteolysis on PRG22. In 
contrast, PLA2 activity was sustained at a basal level until 
PRG21, increased from PRG22 and further increased on 
PRG23 (to 494% of PRG19, P< 0.05). Previous researchers 
did not detect a rise in PLA2 activity until 1 2 days after 
parturition [17]. This discrepancy can possibly be explained 
by the fact that, in that study, the activity in a whole ovarian 
microsome was measured using a method somewhat different 
from more conventional ones, including ours [7-9,11,14]. We 
consider our present data to be more reliable and to reflect the 
luteal nature during functional regression with accuracy. This 
might be supported by the finding that luteal PGF2a showed a 
marked (4.7-fold) increase from PRG21 to PRG22 followed 
by a slight decrease on PRG23 (Table 1). Olofsson et al. [18] 
demonstrated that in vivo levels of PGF2~, PGE2 and pros- 
tacyclin in rat CLs were decreased from PRG7 and suppressed 
at a very low level until PRG19 and that all three prostanoids 
showed a quite similar pattern. Taken these findings, our data 
support he CL as the critical source of the luteolytic PG and 
indicate that luteal PG levels are suppressed in the late preg- 
nancy and dramatically increase before parturition. Since in- 
duction of timely luteolysis is obligatory for a successful de- 
livery, the tightly regulated mechanism of luteal PLA2 
activation and PGF2~ synthesis must operate in late preg- 
nancy. 
We also found the sustained increase in the PLA2 activity 
and PGF2a level during early post-partum. Functionally re- 
gressed rat CL undergo the following structural involution 
under the luteolytic influence of PRL [19] and its secretion 
by the pituitary in post-partum rats is induced by pups' suck- 
ling stimulus [20]. We confirmed that the weight of a post- 
partum CL of mothers with suckling stimulus decreased to 
46.7% until PP8 (Fig. 1A). Histological examination verified 
the decreasing size and fibrotic replacement of a pregnant CL 
(Fig. 3A). Luteal PLA2 activity showed a transient but sig- 
nificant increase on PP5 and decreased gradually on PP8 (Fig. 
1B). Accordingly, the luteal PGF2~ level showed a quite sim- 
ilar temporal pattern (Fig. 1C). These findings may also im- 
plicate PLA2 and its metabolitc PGF2a in structural luteolysis, 
especially in its early period. 
Employing the delayed structural luteolysis model, we 
measured the luteal PLA2 activity and PGF2~ level. The CL 
of the mother without suckling stimulus became smaller but 
significantly larger than that of the mother with suckling stim- 
ulus on PP8 (Fig. 1A). Histological studies established the 
existence of a large-sized pregnant CL and a slightly discern- 
ible appearance between the pregnant CL and the new CL 
derived from post-partum ovulation (data not shown). In 
these PRL-depleted mothers, the fluctuation in luteal PLA2 
activity was altered and appeared to be delayed by the aug- 
mentation of enzyme activity (Fig. 1 B). It is more notable that 
luteal PGF2a was potently suppressed as late as PP8 (Fig. 1C). 
Since these changes might be induced by the deficiency or 
A 
Fig. 3. Immunohistochemistry of cPLA2 and PLA2-IB in post-par- 
rum CLs. The mother with suckling stimuli was killed on PP8 and 
the ovaries were xamined histologically. (A) HE staining of the 
ovary possessing pregnant CLs (O) and new CLs derived from post- 
partum ovulation (N). (B) anti-cPLAs staining (×1000), (C) anti- 
PLA2-1B staining (×3000). Note that the pregnant and new CLs 
exhibit a similar immunoreactivity for cPLA2 but distinct reaction 
for PLA2-IB. Magnification, X40. 
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absence of PRL, we subsequently tested the possible reversal 
effect of exogenous PRL. We found a small but significant 
decrease in weight, a subtle increased PLA2 activity and a 
drastic rise in PGF2,~ in PRL-treated CLs (Fig. 1). As PRL 
is shown to up-regulate PLA2-IB and cyclooxygenase-2 
(COX-2) expression, thus stimulating PGE2 production in 
uterine stromal cells [21], the pituitary hormone may provoke 
luteal PG synthesis through activation of the COX system as 
well as the PLA2 system. Collectively, our data provide evi- 
dence that PRL-induced structural luteolysis involves the en- 
hanced PG synthesis, being partially mediated by PLA2 acti- 
vation. 
We characterized PLA2 enzymes in pregnant rat CLs using 
various inhibitors and immunohistochemistry. Although 
cPLA2 was assumed to be the primary isoform in a pseudo- 
pregnant rat CL [5,7], ATK was not so effective in pregnant 
CLs on either PP0 or PP5 (25 35% inhibition) (Fig. 2). We 
identified a slight signal for cPLA2 in pregnant CLs as well as 
in newly formed CLs (Fig. 3B). Our results suggest he pres- 
ence but less important role of cPLA2 in pregnant CLs. 
Rather, BEL and MAFP were more potent, suggestive of 
the substantial contribution of iPLA2. Additionally, DTT 
was also more effective. Since immunoreactive PLAz-IB was 
found exclusively in newly formed CLs (Fig. 3C), the DTT- 
sensitive activity may be expressed by PLA2-IIA. From ob- 
tained results, we speculate that several isoforms of PLA2 
(cPLA2, iPLA2 and sPLA2) may exist and function concert- 
edly in pregnant rat CLs. Luteolysis is considered as the apop- 
totic cell death process. Stimulation of the apoptosis ignalling 
receptors uch as tumor necrosis factor receptor and Fas often 
leads to the activation of PEA2, including cPLAx [22 24], 
iPLA2 [25] and sPLA2 [24,26]. Further studies are needed to 
clarify the complex mechanism of PLA2 regulation in apop- 
tosis of pregnant rat CLs. 
In summary, this study is the first demonstration that the 
luteal PLA2 activity in pregnant rats rises during functional 
luteolysis at term and more prominently during structural 
luteolysis after delivery. The increased activity may partially 
mediate PRL-induced structural regression through PGF2~ 
production. 
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